H

Hualan Biological Bacterin Inc
SZSE:301207

Watchlist Manager
Hualan Biological Bacterin Inc
SZSE:301207
Watchlist
Price: 19.12 CNY -5.3% Market Closed
Market Cap: 11.5B CNY
Have any thoughts about
Hualan Biological Bacterin Inc?
Write Note

Relative Value

The Relative Value of one Hualan Biological Bacterin Inc stock under the Base Case scenario is 34.67 CNY. Compared to the current market price of 19.12 CNY, Hualan Biological Bacterin Inc is Undervalued by 45%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
34.67 CNY
Undervaluation 45%
Relative Value
Price
H
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
74
vs Industry
66
Median 3Y
6.8
Median 5Y
6.8
Industry
7.7
Forward
4.8
vs History
77
vs Industry
9
Median 3Y
19.4
Median 5Y
19.4
Industry
22.7
Forward
13.7
vs History
77
vs Industry
11
Median 3Y
27.3
Median 5Y
27.3
Industry
21.6
vs History
42
vs Industry
8
Median 3Y
15.6
Median 5Y
15.6
Industry
25.2
vs History
80
vs Industry
49
Median 3Y
2.9
Median 5Y
2.9
Industry
2.5
vs History
77
vs Industry
62
Median 3Y
5.6
Median 5Y
5.6
Industry
7.7
Forward
3.6
vs History
77
vs Industry
60
Median 3Y
6.9
Median 5Y
6.9
Industry
9
vs History
74
vs Industry
10
Median 3Y
14.7
Median 5Y
14.7
Industry
4.2
Forward
6.2
vs History
74
vs Industry
9
Median 3Y
14.7
Median 5Y
14.7
Industry
4.1
Forward
14.3
vs History
77
vs Industry
12
Median 3Y
24.8
Median 5Y
24.8
Industry
5.7
vs History
48
vs Industry
9
Median 3Y
12.7
Median 5Y
12.7
Industry
3.6
vs History
80
vs Industry
51
Median 3Y
2.9
Median 5Y
2.9
Industry
4.6

Multiples Across Competitors

Competitors Multiples
Hualan Biological Bacterin Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Hualan Biological Bacterin Inc
SZSE:301207
11.5B CNY 5 14.3 10.5 10.5
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 888 840.5 -180 080 -218 674.5 -216 179.2
US
Abbvie Inc
NYSE:ABBV
314.7B USD 5.7 61.9 15.4 23.7
US
Amgen Inc
NASDAQ:AMGN
157B USD 4.8 37.1 17.4 32.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.2B USD 4 890.3 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 859.4 -474.5 -516.7 -502.9
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 6 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.9 -54.9 -59 -53.2
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.6 -130.6 -105.1 -76.6
P/E Multiple
Earnings Growth
CN
H
Hualan Biological Bacterin Inc
SZSE:301207
Average P/E: 175.7
14.3
49%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 080 N/A
US
Abbvie Inc
NYSE:ABBV
61.9
412%
US
Amgen Inc
NASDAQ:AMGN
37.1
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
890.3
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -474.5 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.9 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -130.6 N/A
EV/EBITDA Multiple
EBITDA Growth
CN
H
Hualan Biological Bacterin Inc
SZSE:301207
Average EV/EBITDA: 16.2
10.5
115%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -218 674.5 N/A
US
Abbvie Inc
NYSE:ABBV
15.4
28%
US
Amgen Inc
NASDAQ:AMGN
17.4
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
38%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -516.7 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -105.1 N/A
EV/EBIT Multiple
EBIT Growth
CN
H
Hualan Biological Bacterin Inc
SZSE:301207
Average EV/EBIT: 20.8
10.5
-4%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 179.2 N/A
US
Abbvie Inc
NYSE:ABBV
23.7
88%
US
Amgen Inc
NASDAQ:AMGN
32.9
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -502.9 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.2 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.6 N/A

See Also

Discover More
Back to Top